Lyfebulb
Lyfebulb is an innovation accelerator that focuses on enhancing the lives of individuals affected by chronic diseases. By directly engaging with patient communities and their care partners, the company generates valuable insights and develops new solutions tailored to their needs. Lyfebulb operates an online digital platform that aims to reduce the burden of chronic disease through education, innovation, and connectivity. Through this patient empowerment approach, the company seeks to create and introduce groundbreaking products to the healthcare market, effectively bridging the gap between patients and the broader healthcare industry.
UE LifeSciences
Grant in 2019
UE LifeSciences is a growth-stage FemTech company focused on preventive oncology, particularly in the area of non-invasive breast and cervical cancer detection. The company has developed a portable screening device that aids in the early detection of breast cancer, allowing patients to receive timely treatments. Its flagship product has received regulatory clearance and has been validated through independent trials, demonstrating its effectiveness. This product is currently scaling commercially across multiple markets and operates on a high-margin, pay-per-use revenue model. Collaborations with major pharmaceutical companies further enhance its reach, opening opportunities in national markets. UE LifeSciences also has a promising pipeline of additional products aimed at improving cancer detection and treatment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.